Jacques Jean Bienaime

Affiliations

  • at Immunome Inc. (IMNM), 2025-06-12
  • Director at Incyte Corp (INCY), 2025-06-12
  • at Keros Therapeutics Inc. (KROS), 2025-06-06
  • Director at Biomarin Pharmaceutical Inc (BMRN), 2024-05-21
  • Director at Vital Therapies Inc (VTL), 2018-09-24
  • Director at Intermune Inc (ITMN), 2014-10-02
  • Director at Portola Pharmaceuticals Inc (PTLA), 2014-05-19
  • Director at Neurogesx Inc (NGSX), 2012-02-09
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IMNM $9.38 5,000 $46,900.00 36,415 2025-06-03 Filing
IMNM $7.78 7,800 $60,684.00 31,415 2025-03-25 Filing
IMNM $8.21 7,000 $57,470.00 23,615 2025-03-24 Filing
IMNM $13.94 7,000 $97,608.00 16,615 2024-08-16 Filing
IMNM $13.57 2,000 $27,139.80 9,615 2024-05-21 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BMRN $81.14 20,000 $1,622,800.00 474,994 2024-05-10 Filing
BMRN $81.62 20,000 $1,632,400.00 474,994 2024-05-09 Filing
BMRN $91.26 20,000 $1,825,200.00 474,994 2024-04-12 Filing
BMRN $90.99 20,000 $1,819,800.00 474,994 2024-04-11 Filing
BMRN $86.71 1,000 $86,713.00 560,203 2024-03-06 Filing